Zacks Research Issues Optimistic Forecast for BPMC Earnings
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Equities researchers at Zacks Research upped their Q1 2025 earnings per share (EPS) estimates for shares of Blueprint Medicines in a research report issued to clients and investors on Wednesday, March 5th. Zacks Research analyst A. Chakraborty now forecasts that the biotechnology company will post earnings of […]
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Equities researchers at Zacks Research upped their Q1 2025 earnings per share (EPS) estimates for shares of Blueprint Medicines in a research report issued to clients and investors on Wednesday, March 5th. Zacks Research analyst A. Chakraborty now forecasts that the biotechnology company will post earnings of […]
